Molecular Diseases 3 by Prof Sami a Al-Mudhaffar Dr - Bookswagon
Home > Medicine > Clinical & internal medicine > Medical diagnosis > Molecular Diseases 3
Molecular Diseases 3

Molecular Diseases 3


     0     
5
4
3
2
1



International Edition


About the Book

Serum LH level was measured in three groups of individuals, by Immunoradiometric assay (IRMA). Group one consisted of (8) premenopausal women suffering from benign serous ovarian tumor. Group two consisted of (4) premenopausal women suffering from malignant serous ovarian tumor. Group three consisted of (10) control premenopausal women. The presence of LH was investigated in two groups of benign serous ovarian tumors and one group of malignant serous ovarian tumors. The results obtained indicate a higher incidence of LH in the malignant tumors than in the benign tumors.The characteristics of the binding of 125I-anti LH antibody with LH in pre-and postmenopausal patients with benign and malignant serous ovarian tumors homogenate were investigated. Different factors affecting this binding was extensively studied such as, pH, time, temperature, salts, the concentration of 125I-anti LH antibody and the concentration of LH. The time-course of 125I-anti LH antibody with LH in pre-and postmenopausal patients with benign and malignant serous ovarian tumors homogenate was studied at five different temperatures. The obtained data have obeyed pseudo-first order Kinetics for the association of 125I-anti LH antibody with LH. The kinetic parameters K+1, K-1, Ka, and Kd of the binding of 125I-anti LH antibody with LH in pre-and postmenopausal patients with benign and malignant serous ovarian tumors were determined at five different temperatures. The thermodynamic of the 125I-anti LH antibody binding with LH in pre-and postmenopausal patients with benign and malignant serous ovarian tumors was studied by using Van't Hoff and Arrhenius equations. From these equations the thermodynamic parameters of the standard state ( ) and the transition state ( and also Ea) were determined. The (125I-anti LH antibody/LH) complex was isolated from the unbound 125I-anti LH antibody by gel filtration technique in pre-and postmenopausal patients with benign and malignant serous ovarian tumors. The absorption spectra of the isolated complex and the unbound 125I-anti LH antibody were studied. Spectroscopic studies in the U.V region were carried out on the unbound 125I-anti LH antibody and (125I-anti LH antibody/LH) complex in premenopausal patients with malignant serous ovarian tumors. The effect of pH and polarity on the spectra and observation of the thermal stability of (125I-anti LH antibody/LH) complex were studied.Immunoradiomatric assay technique was used to measure the level of serum tumor markers CA125 and CEA in 30 healthy women, 24 patients with benign ovarian tumors and 34 patients with malignant ovarian tumors. Upon comparison of the results, the CA125 level was found above normal (35u.ml-1) in 80% of patients with ovarian cancer, while CEA level was elevated in 44% of patients with ovarian cancer (more than 3.0 u.ml-1). Among the pre-menopausal women, the values of CA125 and CEA in sera of patients with malignant ovarian tumors were found to be significantly higher (P


Best Sellers



Product Details
  • ISBN-13: 9781987789157
  • Publisher: Createspace Independent Publishing Platform
  • Publisher Imprint: Createspace Independent Publishing Platform
  • Height: 254 mm
  • No of Pages: 364
  • Series Title: Moleculular Diseases
  • Sub Title: M0leules
  • Width: 178 mm
  • ISBN-10: 1987789156
  • Publisher Date: 13 Apr 2018
  • Binding: Paperback
  • Language: English
  • Returnable: N
  • Spine Width: 19 mm
  • Weight: 680 gr


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Molecular Diseases 3
Createspace Independent Publishing Platform -
Molecular Diseases 3
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Molecular Diseases 3

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals



    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!